Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Inhibiting effect of eplerenone for activation/proliferation of helper T cells of chronic heart failure patients

A technology for chronic heart failure and eplerenone, which is applied to medical preparations containing active ingredients, allergic diseases, organic active ingredients, etc., and can solve problems such as ALD escape

Inactive Publication Date: 2018-01-12
XINJIANG MEDICAL UNIV
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

ACEI and β-receptor blockers can reduce the release of ALD in heart failure, but the long-term application of ACEI will appear "ALD escape" phenomenon

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhibiting effect of eplerenone for activation/proliferation of helper T cells of chronic heart failure patients
  • Inhibiting effect of eplerenone for activation/proliferation of helper T cells of chronic heart failure patients
  • Inhibiting effect of eplerenone for activation/proliferation of helper T cells of chronic heart failure patients

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] 1. Materials and methods

[0027] 1.1 Materials

[0028] 1.1.1 Experimental objects and case screening conditions Experimental group: 30 cases, all inpatients in the Department of Heart Failure, The First Affiliated Hospital of Xinjiang Medical University, including 18 males and 12 females, aged 32-69 (48.34±4.86) years old . Inclusion criteria: (a) diagnosed with CHF for at least 3 months; (b) NYHA cardiac function class 2-3; exclusion criteria: (a) acute and chronic infection, inflammatory disease; (b) autoimmune disease; (c) recent unstable angina pectoris and acute myocardial infarction (within 3 months); (d) rheumatic diseases with recent (within 3 months) rheumatic activity; (e) diabetes, hyperthyroidism or other endocrine diseases; ( f) Recent use of drugs that affect the immune response (such as corticosteroids); (g) severe liver and renal insufficiency; (h) tumors; (i) pregnancy. Control group: 20 cases, all selected from outpatient health checkups, 10 males...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses influences of eplerenone (EPL) for expression of mRNA and protein from the channels including Kv1.3 and the like of CD4+T lymphocytes of chronic heart failure (CHF) patients, and the result shows that eplerenone has an inhibiting effect for the activation / proliferation of the CD4+T lymphocytes of the chronic heart failure patients. The research result proves that the expression of mRNA from the channels including Kv1.3, KCa3.1 and CRAC of the CD4+T lymphocytes of the chronic heart failure patients is obviously increased compared with that of the normal group, after 30 [mu] M of eplerenone is administrated, the expression of mRNA is obviously inhibited, wherein the inhibiting for the Kv1.3 channel is the most obvious, the inhibiting rate is about 64.8% (P is smallerthan 0.01), therefore, eplerenone has good significance for detecting the protein of the Kv1.3 channel. The protein of Kv1.3 of the CHF group is increased by 120.8%, and 39.6% (P is smaller than 0.01)is inhibited after 30 [mu] M of eplerenone is added.

Description

technical field [0001] The invention relates to the inhibitory effect of eplerenone on the activation / proliferation of helper T cells in patients with chronic heart failure. Background technique [0002] Chronic heart failure (CHF) is the long-term accumulation of myocardial extracellular matrix (fibroblasts, collagen, matrix metalloproteinases, etc.), resulting in ventricular stiffness and impaired diastolic filling. The current research on the mechanism of chronic heart failure mainly involves the activation of neuroendocrine system and immune system RAAS. RAAS overactivation is the main cause of myocardial fibrosis, so ACEI and β-receptor blockers are classically used to prevent and reverse myocardial fibrosis. A large number of studies have shown that aldosterone (ALD) plays a role in coronary heart disease through its signal transduction pathway. , acute myocardial infarction, myocardial ischemia and heart failure play a key role in the occurrence and development. ACE...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/585A61P9/04A61P37/06
Inventor 程路峰伊力哈木江·克尤木徐琦李少华邵培培刘长江武洋周勇
Owner XINJIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com